Form 4: Hims & Hers Health Director Christiane Pendarvis Reports Stock Vesting

Sentiment:

SEC Form 4 Filing


Director Christiane Pendarvis reports the vesting of 19,707 Restricted Stock Units (RSUs) convertible to Class A Common Stock on June 6, 2024, resulting in a total direct ownership of 30,917 Class A Common Stock shares.

Summary

  • Christiane Pendarvis, a director of Hims & Hers Health, Inc., filed a Form 4 on June 10, 2024.
  • The form reports the vesting of 19,707 Restricted Stock Units (RSUs) on June 6, 2024.
  • These RSUs convert into Class A Common Stock on a 1:1 basis.
  • Following the transaction, Pendarvis directly owns 30,917 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing regarding stock vesting, which is neither particularly positive nor negative.

Positives

  • The vesting of RSUs indicates continued alignment of the director's interests with those of the shareholders.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

  • The vesting of RSUs aligns the director's interests with those of the shareholders, potentially encouraging decisions that benefit the company's long-term value.

Key Dates

DateDescription
06/06/2024Date of RSU vesting and the company's 2024 annual stockholders meeting.
06/10/2024Date of Form 4 filing.
06/15/2024Alternative vesting date for RSUs, subject to continuous service.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.